Mostrar o rexistro simple do ítem

dc.contributor.authorCalviño Suárez, Cristina*
dc.contributor.authorFerreiro Iglesias, Rocio *
dc.contributor.authorBastón Rey, Iria *
dc.contributor.authorBarreiro de Acosta, Manuel*
dc.date.accessioned2025-09-10T08:41:45Z
dc.date.available2025-09-10T08:41:45Z
dc.date.issued2023
dc.identifier.citationCalvino-Suarez C, Ferreiro-Iglesias R, Baston Rey I, Barreiro-de Acosta M. Managing ulcerative colitis after surgery. Vol. 9, Frontiers in Medicine. Frontiers Media S.A.; 2023.
dc.identifier.issn2296-858X
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/63e7d77537a0683d533f67f6
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21712
dc.description.abstractManagement of ulcerative colitis after surgery suggested by guidelines (total proctocolectomy with ileal-pouch anal anastomosis) is a big challenge for physicians because patients who believed that their disease had been cured started experiencing very uncomfortable symptoms repeatedly. A high number of patients develop episodes of pouchitis, which is a non-specific inflammation of the pouch whose etiology is unknown. Antibiotics are the elective treatment for acute pouchitis, but regarding chronic pouchitis, this condition is very complicated to treat due to the absence of well-designed specific studies for this group of patients. Antibiotics, budesonide, and biological therapies are some of the recommended drugs for these patients, but despite their use, some need a permanent ileostomy.
dc.description.sponsorshipCC-S has served as a speaker for or has received research funding from MSD, AbbVie, Janssen, Takeda, and Adacyte. RF-I has served as a speaker for or has received research funding from Takeda, MSD, Abbvie, Janssen, Pfizer, Palex, Shire Pharmaceuticals, Tillotts Pharma, Dr. Falk Pharma, Ferring, Adacyte, and Casenrecordati. IB has received financial support for traveling and educational activities from or has served as an advisory board member for Abbvie, Janssen, Takeda, Pfizer, Faes Farma, and Adacyte. MB-d has served as an advisory board member for and has received financial support for research and/or training activities from MSD, AbbVie, Pfizer, Kern Pharma, Biogen, Takeda, Janssen, Galapagos, Lilly, Ferring, Faes Farma, Dr. Falk Pharma, Chiesi, Gebro, and Adacyte.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleManaging ulcerative colitis after surgery
dc.typeArtigo
dc.authorsophosCalvino-Suarez, C.; Ferreiro-Iglesias, R.; Baston Rey, I.; Barreiro-de Acosta, M.
dc.identifier.doi10.3389/fmed.2022.1081940
dc.identifier.sophos63e7d77537a0683d533f67f6
dc.journal.titleFrontiers in Medicine*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Dixestivo
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Dixestivo
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Dixestivo
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Dixestivo
dc.relation.projectIDMSD
dc.relation.projectIDAbbVie
dc.relation.projectIDJanssen
dc.relation.projectIDTakeda
dc.relation.projectIDAdacyte
dc.relation.projectIDPfizer
dc.relation.projectIDPalex
dc.relation.projectIDShire Pharmaceuticals
dc.relation.projectIDTillotts Pharma
dc.relation.projectIDDr. Falk Pharma
dc.relation.projectIDFerring
dc.relation.projectIDCasenrecordati
dc.relation.projectIDFaes Farma
dc.relation.projectIDKern Pharma
dc.relation.projectIDBiogen
dc.relation.projectIDGalapagos
dc.relation.projectIDLilly
dc.relation.projectIDChiesi
dc.relation.projectIDGebro
dc.relation.publisherversionhttps://doi.org/10.3389/fmed.2022.1081940
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo de Revisión
dc.volume.number9


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution 4.0 International (CC BY 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)